Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a ...